Clinical Trial Update: Diagnostic Performance and Safety of 18F-NaF-PET/CT in Bone Metastases Compared With 99mTc⁃MDP-BS±SPECT [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing 18F-NaF-PET/CT to 99mTc-MDP-BS±SPECT for diagnostic performance and safety in bone metastases; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases

Drugs mentioned

• 18F-NaF-PET/CT (fluoride f18 positron emission tomography/computed tomography)
• 99mTc-MDP-BS±SPECT (technetium-99m methylene diphosphonate with bone scan ± SPECT)

Snippet

Sponsor: HTA Co., Ltd. | Conditions: Bone Metastases | Phase 3 | Status: COMPLETED